Have a feature idea you'd love to see implemented?
Let us know!
AEMD Aethlon Medical Inc
Price (delayed)
$0.3854
Market cap
$5.38M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.82
Enterprise value
-$800,480
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier
Highlights
Aethlon Medical's EPS has increased by 42% YoY and by 27% QoQ
The company's debt fell by 8% QoQ
AEMD's revenue has plunged by 100% YoY
Aethlon Medical's gross profit has shrunk by 100% YoY
Key stats
What are the main financial stats of AEMD
Market
Valuations
Earnings
Shares outstanding
13.96M
Market cap
$5.38M
Enterprise value
-$800,480
Price to earnings (P/E)
N/A
Price to book (P/B)
0.89
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$11.27M
EBITDA
-$10.92M
Free cash flow
-$8.92M
Per share
Balance sheet
Liquidity
EPS
-$2.82
Free cash flow per share
-$0.64
Book value per share
$0.43
Revenue per share
$0
TBVPS
$0.63
Total assets
$8.85M
Total liabilities
$2.83M
Debt
$798,452
Equity
$6.02M
Working capital
$4.81M
Debt to equity
0.13
Current ratio
3.06
Quick ratio
2.99
Net debt/EBITDA
0.57
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-115.8%
Return on equity
-160.4%
Return on invested capital
-1,111.6%
Return on capital employed
-173%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AEMD stock price
How has the Aethlon Medical stock price performed over time
Intraday
-1.15%
1 week
-3.29%
1 month
-5.4%
1 year
-77.06%
YTD
-82.4%
QTD
-17.37%
Financial performance
How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.58M
Net income
-$11.27M
Gross margin
N/A
Net margin
N/A
AEMD's revenue has plunged by 100% YoY
Aethlon Medical's gross profit has shrunk by 100% YoY
The net income has increased by 3.1% year-on-year
The company's operating income rose by 2.8% YoY and by 2.3% QoQ
Growth
What is Aethlon Medical's growth rate over time
Valuation
What is Aethlon Medical stock price valuation
P/E
N/A
P/B
0.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has increased by 42% YoY and by 27% QoQ
The company's equity fell by 42% YoY and by 31% QoQ
The P/B is 31% below the 5-year quarterly average of 1.3 but 13% above the last 4 quarters average of 0.8
AEMD's revenue has plunged by 100% YoY
Efficiency
How efficient is Aethlon Medical business performance
The ROE has plunged by 92% YoY and by 13% from the previous quarter
Aethlon Medical's ROIC has plunged by 77% YoY and by 29% from the previous quarter
The ROA has plunged by 66% YoY and by 8% from the previous quarter
Dividends
What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AEMD.
Financial health
How did Aethlon Medical financials performed over time
Aethlon Medical's current ratio has shrunk by 50% YoY and by 32% QoQ
The quick ratio has plunged by 50% YoY and by 31% from the previous quarter
The company's debt is 87% lower than its equity
The debt to equity has surged by 63% year-on-year and by 30% since the previous quarter
The company's equity fell by 42% YoY and by 31% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.